Actavis PLC (NYSE:ACT)

289.74
Delayed Data
As of May 01
 +6.88 / +2.43%
Today’s Change
193.00
Today|||52-Week Range
317.72
+12.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$113.8B

Company Description

Actavis plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products. The company operates through the following segments: North American Brands, North American Generics and International, and Anda. Actavis was founded on October 1, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Actavis Plc
1 Grand Canal Square
Dublin Dublin 2
P:3538622617000
Investor Relations:
(862) 261-7152

Employees

Shareholders

Other institutional46.34%
Mutual fund holders42.02%
Individual stakeholders0.27%

Top Executives

Brenton L. SaundersPresident, Chief Executive Officer & Director
Robert A. StewartChief Operating Officer
Maria Teresa HiladoChief Financial Officer
William J. MeuryExecutive VP & President-Branded Pharma
Jonathon KellermanGlobal Chief Compliance Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account